A Double-Blind, Placebo-Controlled, Parallel, Proof of Concept Trial to Assess the Tolerability, Safety, and Efficacy of Rotigotine Nasal Spray for the Acute Treatment of "OFF" Symptoms in Subjects With Advanced-Stage, Idiopathic Parkinson Disease.

Trial Profile

A Double-Blind, Placebo-Controlled, Parallel, Proof of Concept Trial to Assess the Tolerability, Safety, and Efficacy of Rotigotine Nasal Spray for the Acute Treatment of "OFF" Symptoms in Subjects With Advanced-Stage, Idiopathic Parkinson Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Parkinson's disease
  • Focus Proof of concept; Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 23 Jun 2009 Sponsor and lead trial centre (UCB), actual number of patients (82) added as reported by ClinicalTrials.gov.
    • 19 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top